Shares of Dentsply Sirona Inc. XRAY, -5.30% tumbled 9.5% in premarket trading Monday, after the dental products maker reported third-quarter results that were well below expectations and cuts its full-year outlook, citing weaker demand, supply chain challenges and unfavorable currency translation. The company swung to a net loss of $1.08 billion, or $5.01 a share, from net income of $84 million, or 38 cents a share, in the year-ago period. Excluding nonrecurring items, such as a $1.1 billion charge due to weakened demand, higher costs and foreign currency impacts, adjusted earnings per share fell to 41 cents from 60 cents, and missed the FactSet consensus of 53 cents. Sales fell 8.9% to $947 billion, below the FactSet consensus of $1.02 billion. For 2022, the company cut its guidance ranges for adjusted EPS to $1.90 to $2.00 from $2.35 to $2.55 and for sales to $3.85 billion to $3.88 billion from $4.1 billion to $4.2 billion. The results come after the company announced the restatement of third-quarter 2021 results following the completion of an internal investigation into reporting matters. The company said it has initiated a “comprehensive review” of its business to improve execution and return to growth. “”We are not satisfied with third quarter results, however this quarter marks an important turning point as we enter our company’s next chapter,” said Chief Executive Simon Campion. The stock has sunk 14.9% over the past three months through Friday, while the S&P 500 SPX, -0.89% has shed 6.7%.